S&P 500   3,990.40 (+0.49%)
DOW   32,514.53 (+0.86%)
QQQ   310.05 (-0.27%)
AAPL   158.90 (-0.84%)
MSFT   276.85 (-1.33%)
META   203.67 (-1.14%)
GOOGL   103.08 (-2.24%)
AMZN   98.66 (+0.54%)
TSLA   193.42 (+1.58%)
NVDA   266.64 (-0.43%)
NIO   9.01 (-0.66%)
BABA   86.24 (-0.76%)
AMD   97.27 (-0.69%)
T   18.92 (+1.67%)
F   11.59 (+0.70%)
MU   60.46 (-1.14%)
CGC   1.89 (-0.79%)
GE   93.59 (+2.43%)
DIS   95.84 (+1.87%)
AMC   4.52 (+1.12%)
PFE   40.41 (+0.05%)
PYPL   73.66 (-0.30%)
NFLX   328.42 (+0.01%)
S&P 500   3,990.40 (+0.49%)
DOW   32,514.53 (+0.86%)
QQQ   310.05 (-0.27%)
AAPL   158.90 (-0.84%)
MSFT   276.85 (-1.33%)
META   203.67 (-1.14%)
GOOGL   103.08 (-2.24%)
AMZN   98.66 (+0.54%)
TSLA   193.42 (+1.58%)
NVDA   266.64 (-0.43%)
NIO   9.01 (-0.66%)
BABA   86.24 (-0.76%)
AMD   97.27 (-0.69%)
T   18.92 (+1.67%)
F   11.59 (+0.70%)
MU   60.46 (-1.14%)
CGC   1.89 (-0.79%)
GE   93.59 (+2.43%)
DIS   95.84 (+1.87%)
AMC   4.52 (+1.12%)
PFE   40.41 (+0.05%)
PYPL   73.66 (-0.30%)
NFLX   328.42 (+0.01%)
S&P 500   3,990.40 (+0.49%)
DOW   32,514.53 (+0.86%)
QQQ   310.05 (-0.27%)
AAPL   158.90 (-0.84%)
MSFT   276.85 (-1.33%)
META   203.67 (-1.14%)
GOOGL   103.08 (-2.24%)
AMZN   98.66 (+0.54%)
TSLA   193.42 (+1.58%)
NVDA   266.64 (-0.43%)
NIO   9.01 (-0.66%)
BABA   86.24 (-0.76%)
AMD   97.27 (-0.69%)
T   18.92 (+1.67%)
F   11.59 (+0.70%)
MU   60.46 (-1.14%)
CGC   1.89 (-0.79%)
GE   93.59 (+2.43%)
DIS   95.84 (+1.87%)
AMC   4.52 (+1.12%)
PFE   40.41 (+0.05%)
PYPL   73.66 (-0.30%)
NFLX   328.42 (+0.01%)
S&P 500   3,990.40 (+0.49%)
DOW   32,514.53 (+0.86%)
QQQ   310.05 (-0.27%)
AAPL   158.90 (-0.84%)
MSFT   276.85 (-1.33%)
META   203.67 (-1.14%)
GOOGL   103.08 (-2.24%)
AMZN   98.66 (+0.54%)
TSLA   193.42 (+1.58%)
NVDA   266.64 (-0.43%)
NIO   9.01 (-0.66%)
BABA   86.24 (-0.76%)
AMD   97.27 (-0.69%)
T   18.92 (+1.67%)
F   11.59 (+0.70%)
MU   60.46 (-1.14%)
CGC   1.89 (-0.79%)
GE   93.59 (+2.43%)
DIS   95.84 (+1.87%)
AMC   4.52 (+1.12%)
PFE   40.41 (+0.05%)
PYPL   73.66 (-0.30%)
NFLX   328.42 (+0.01%)
Positive News Sentiment  
NASDAQ:TCRX

TScan Therapeutics - TCRX News Today

$2.35
+0.03 (+1.29%)
(As of 03/27/2023 02:29 PM ET)
Add
Compare
Today's Range
$2.30
▼
$2.39
50-Day Range
$1.73
▼
$3.32
52-Week Range
$1.45
▼
$4.56
Volume
12,908 shs
Average Volume
167,577 shs
Market Capitalization
$56.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.00
Get TScan Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TCRX and its competitors with MarketBeat's FREE daily newsletter.


TCRX Media Mentions By Week

TCRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TCRX
News Sentiment
▼
1.87

0.71
▲
Average
Medical
News Sentiment

TCRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TCRX Articles
This Week
▼
1

0
▲
TCRX Articles
Average Week

SourceHeadline
marketwatch.com logoTScan Therapeutics Shares Rise 8% After First Patient Dosed With TSC-101
marketwatch.com - March 15 at 12:55 PM
finance.yahoo.com logoTScan Therapeutics Announces First Patient Dosed in Phase 1 Umbrella Clinical Trial Evaluating TSC-100 and TSC-101 for the Treatment of Hematologic Malignancies
finance.yahoo.com - March 14 at 8:14 AM
finance.yahoo.com logoTScan Therapeutics to Participate in the Barclays Global Healthcare Conference
finance.yahoo.com - March 13 at 4:51 PM
msn.com logoTScan Therapeutics's Return On Capital Employed Insights
msn.com - March 10 at 6:08 PM
finance.yahoo.com logoTScan Therapeutics Full Year 2022 Earnings: Misses Expectations
finance.yahoo.com - March 10 at 8:51 AM
markets.businessinsider.com logoAnalysts Have Conflicting Sentiments on These Healthcare Companies: AbbVie (ABBV) and TScan Therapeutics (TCRX)
markets.businessinsider.com - March 9 at 6:56 AM
markets.businessinsider.com logoH.C. Wainwright Keeps Their Buy Rating on TScan Therapeutics (TCRX)
markets.businessinsider.com - March 9 at 6:56 AM
msn.com logoTScan Therapeutics GAAP EPS of -$0.78 misses by $0.08, revenue of $3.09M misses by $1.01M
msn.com - March 8 at 10:55 AM
finance.yahoo.com logoTScan Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Upcoming Milestones
finance.yahoo.com - March 8 at 10:55 AM
finance.yahoo.com logoTScan Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference
finance.yahoo.com - March 1 at 8:19 AM
finance.yahoo.com logoTScan Therapeutics Announces Presentation at the H.C. Wainwright Cell Therapy Virtual Conference
finance.yahoo.com - February 21 at 11:48 AM
markets.businessinsider.com logoTScan Announces FDA Clearance Of 3 INDs For Solid Tumors
markets.businessinsider.com - January 23 at 9:36 AM
msn.com logoTScan stock rises ~15% on FDA nod to start trials of cancer drugs
msn.com - January 23 at 9:36 AM
finance.yahoo.com logoTScan Therapeutics Announces FDA Clearance of Three Investigational New Drug Applications for the Treatment of Solid Tumors
finance.yahoo.com - January 23 at 9:36 AM
finance.yahoo.com logoTScan Therapeutics Announces 2023 Clinical Plans and Highlights Recent Progress
finance.yahoo.com - January 5 at 9:22 AM
finance.yahoo.com logoTScan Therapeutics Presents Phase 1 Umbrella Trial in Progress on HA-1 (TSC-100) and HA-2 (TSC-101) at the 64th American Society of Hematology Annual Meeting 2022
finance.yahoo.com - December 12 at 7:18 AM
finance.yahoo.com logoA number of insiders bought TScan Therapeutics, Inc. (NASDAQ:TCRX) stock last year, which is great news for shareholders
finance.yahoo.com - December 9 at 10:55 AM
finance.yahoo.com logoTScan Therapeutics Named the Highest-Placed Midsize Biotechnology Company in The Top Places to Work for 2022 by The Boston Globe
finance.yahoo.com - December 1 at 2:42 PM
finance.yahoo.com logoTScan Therapeutics to Participate in the 5th Annual Evercore ISI HealthCONx Conference
finance.yahoo.com - November 22 at 11:56 AM
finance.yahoo.com logoTScan Therapeutics Presents Preclinical Data for Solid Tumor Program at the 37th Society for Immunotherapy of Cancer Annual Meeting
finance.yahoo.com - November 11 at 10:21 AM
finanznachrichten.de logoTScan Therapeutics, Inc.: TScan Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
finanznachrichten.de - November 9 at 9:20 AM
finance.yahoo.com logoTScan Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
finance.yahoo.com - November 9 at 9:20 AM
finance.yahoo.com logoTScan Therapeutics Announces Upcoming Virtual Investor Event
finance.yahoo.com - November 7 at 10:25 AM
finance.yahoo.com logoTScan Therapeutics Announces Upcoming Poster Presentation at the 64th American Society of Hematology Annual Meeting and Exposition
finance.yahoo.com - November 3 at 10:53 AM
finance.yahoo.com logoTScan Therapeutics Announces Upcoming Poster Presentations at the 37th Society for Immunotherapy of Cancer Annual Meeting
finance.yahoo.com - October 5 at 10:12 AM
finance.yahoo.com logoTScan Therapeutics Secures Convertible Debt Facility for up to $60 Million with K2 HealthVentures
finance.yahoo.com - September 12 at 10:53 AM
finance.yahoo.com logoTScan Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
finance.yahoo.com - September 7 at 7:53 AM
finance.yahoo.com logoTScan Therapeutics, Inc. (NASDAQ:TCRX) Just Reported Second-Quarter Earnings And Analysts Are Lifting Their Estimates
finance.yahoo.com - August 13 at 12:52 PM
finance.yahoo.com logoNew Forecasts: Here's What Analysts Think The Future Holds For TScan Therapeutics, Inc. (NASDAQ:TCRX)
finance.yahoo.com - August 12 at 10:43 AM
finance.yahoo.com logoTScan Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress
finance.yahoo.com - August 10 at 12:19 PM
finance.yahoo.com logoShareholders in TScan Therapeutics (NASDAQ:TCRX) are in the red if they invested a year ago
finance.yahoo.com - August 5 at 1:10 PM
finance.yahoo.com logoTScan Therapeutics to Participate in the 13th Annual Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 3 at 8:36 AM
finance.yahoo.com logoTScan Therapeutics Announces Publication in Cell Highlighting the Discovery of Tumor Antigens and TCRs for the Treatment of Solid Tumors Using Foundational Screening Technology
finance.yahoo.com - July 11 at 8:56 AM
finance.yahoo.com logoTScan Therapeutics Appoints Debora Barton, M.D., as Chief Medical Officer
finance.yahoo.com - July 7 at 9:58 AM
finance.yahoo.com logoIs TScan Therapeutics (NASDAQ:TCRX) In A Good Position To Invest In Growth?
finance.yahoo.com - July 6 at 6:47 PM
finance.yahoo.com logoTScan Therapeutics to Participate in the LifeSci 2nd Annual Genetic Medicines Symposium
finance.yahoo.com - June 22 at 8:37 AM
finance.yahoo.com logoTScan Therapeutics to Participate in the 2022 Jefferies Healthcare Conference
finance.yahoo.com - June 2 at 8:30 AM
seekingalpha.com logoTScan gets FDA nod to start trial of TSC-101 in blood cancer patients undergoing cell transplant
seekingalpha.com - May 31 at 11:11 AM
finance.yahoo.com logoInsider Buying: The TScan Therapeutics, Inc. (NASDAQ:TCRX) President Just Bought 17% More Shares
finance.yahoo.com - May 22 at 11:32 AM
finance.yahoo.com logoTScan Therapeutics Presents Preclinical Data at the American Society of Gene and Cell Therapy 25th Annual Meeting
finance.yahoo.com - May 19 at 8:50 AM
finance.yahoo.com logoTScan Therapeutics to Participate in the H.C. Wainwright Global Investment Conference
finance.yahoo.com - May 17 at 8:36 AM
finance.yahoo.com logoTScan Therapeutics to Host Virtual KOL Event to Discuss its Solid Tumor Program Strategy and Highlights from the ASGCT 25th Annual Meeting
finance.yahoo.com - May 12 at 8:39 AM
finance.yahoo.com logoTScan Therapeutics Reports First Quarter 2022 Financial Results and Upcoming Anticipated Milestones
finance.yahoo.com - May 9 at 11:42 AM
finance.yahoo.com logoTScan Therapeutics, Inc.'s (NASDAQ:TCRX) recent US$6.0m market cap decline means a loss of US$233k for insiders who bought this year
finance.yahoo.com - May 5 at 3:26 PM
finance.yahoo.com logoTScan Therapeutics Announces Upcoming Presentations at the 25th American Society of Gene and Cell Therapy Annual Meeting
finance.yahoo.com - May 2 at 5:24 PM
finance.yahoo.com logoTScan Therapeutics Appoints Leiden Dworak, CPA, MBA, as Vice President, Finance
finance.yahoo.com - April 11 at 8:53 AM
finance.yahoo.com logoDo Institutions Own TScan Therapeutics, Inc. (NASDAQ:TCRX) Shares?
finance.yahoo.com - February 18 at 5:32 PM
finance.yahoo.com logoTScan Therapeutics Announces Presentation at the 11th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 10 at 6:55 PM
finance.yahoo.com logoFDA Gives Nod To TScan Therapeutics' Early-Stage Trial Of TSC-100 In Hematologic Malignancies
finance.yahoo.com - January 24 at 4:26 PM
seekingalpha.com logoTScan gets FDA nod to start clinical studies for TSC-100 in leukemia patients
seekingalpha.com - January 24 at 9:31 AM
Get TScan Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TCRX and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:TCRX) was last updated on 3/27/2023 by MarketBeat.com Staff